Navigation Links
New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
Date:5/26/2009

are taken in combination with NUCYNTA(TM). When such combined therapy is contemplated, a dose reduction of one or both agents should be considered.

Opioid analgesics can raise cerebrospinal fluid pressure as a result of respiratory depression with carbon dioxide retention. Therefore, NUCYNTA(TM) should not be used in patients susceptible to the effects of raised cerebrospinal fluid pressure such as those with head injury and increased intracranial pressure. Opioid analgesics may obscure the clinical course of patients with head injury due to effects on pupillary response and consciousness. NUCYNTA(TM) should be used with caution in patients with head injury, intracranial lesions, or other sources of preexisting increased intracranial pressure.

NUCYNTA(TM) is a mu-opioid agonist and is a Schedule II controlled substance. Such drugs are sought by drug abusers and people with addiction disorders. Diversion of Schedule II products is an act subject to criminal penalty. NUCYNTA(TM) can be abused in a manner similar to other mu-opioid agonists, legal or illicit. This should be considered when prescribing or dispensing NUCYNTA(TM) in situations where the physician or pharmacist is concerned about an increased risk of misuse and abuse. All patients treated with mu-opioid agonists require careful monitoring for signs of abuse and addition. NUCYNTA(TM) may be abused by crushing, chewing, snorting or injecting the product. These practices pose a significant risk to the abuser that could result in overdose and death.

Patients should be cautioned that NUCYNTA(TM) may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. This is to be expected especially at the beginning of treatment, at any change of dosage as well as in combination with alcohol or tranquilizers.

NUCYNTA(TM) has not been systematically evalu
'/>"/>

SOURCE Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dainippon Sumitomo Pharma Announces Lurasidone Phase III Data in Patients With Schizophrenia
2. Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
3. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
4. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
5. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
6. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
7. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
8. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
9. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
10. Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis
11. Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Syneron Medical Ltd. (NASDAQ: ELOS ), a leading ... three month period ended June 30, 2015. ... Highlights: , Revenue of $73.5 million, up ... American product sales grew 45% year-over-year. , International sales ... product growth in the EMEA region and 25% product growth ...
(Date:8/3/2015)... 3, 2015  Luminex Corporation (NASDAQ: LMNX ) ... June 30, 2015.  Financial and operating highlights for the ... quarter 2015 revenue by 6 percent to $58.9 million, ... second quarter 2015 assay revenue by 22 percent to ... 2014. , Increased Q2 2015 royalty revenue by ...
(Date:8/3/2015)... Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... quarter ended June 30, 2015. All comparisons, unless otherwise noted, ... Second Quarter 2015 Highlights include: , Revenue ... , Total prescriptions dispensed of 234,000, an increase of ... , Adjusted EBITDA of $22.7 million, an increase of 287% ...
Breaking Medicine Technology:Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17Luminex Corporation Reports Record 2nd Quarter 2015 Results 2Luminex Corporation Reports Record 2nd Quarter 2015 Results 3Luminex Corporation Reports Record 2nd Quarter 2015 Results 4Luminex Corporation Reports Record 2nd Quarter 2015 Results 5Luminex Corporation Reports Record 2nd Quarter 2015 Results 6Luminex Corporation Reports Record 2nd Quarter 2015 Results 7Luminex Corporation Reports Record 2nd Quarter 2015 Results 8Luminex Corporation Reports Record 2nd Quarter 2015 Results 9Luminex Corporation Reports Record 2nd Quarter 2015 Results 10Luminex Corporation Reports Record 2nd Quarter 2015 Results 11Luminex Corporation Reports Record 2nd Quarter 2015 Results 12Luminex Corporation Reports Record 2nd Quarter 2015 Results 13Luminex Corporation Reports Record 2nd Quarter 2015 Results 14Luminex Corporation Reports Record 2nd Quarter 2015 Results 15Luminex Corporation Reports Record 2nd Quarter 2015 Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5
(Date:8/4/2015)... ... August 04, 2015 , ... ... at unique artistic expressions from a diverse group of exceptionally talented female artists. ... Music & Art Festival on September 25-27, 2015 in Downtown Las Vegas. Curated ...
(Date:8/4/2015)... ... August 04, 2015 , ... MedicaSoft ... Office of the National Coordinator for Health Information Technology (ONC-HIT) 2014 Edition ... highest quality personal health record and patient portal solution to healthcare providers ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... older brings an automatic end to driving, says the August 2015 Harvard Health ... is okay to drive. It requires an individual assessment of skills," says Lissa ...
(Date:8/4/2015)... ... August 04, 2015 , ... METTLER TOLEDO has announced an ... researchers from Lubrizol, Pfizer, and Merck. This free online seminar will be ... timelines often require informed decisions with limited process understanding. Established methods have ...
(Date:8/4/2015)... ... August 04, 2015 , ... Half of consumers are ... board-certified is increasingly influential in their choice of practitioner, according to new survey ... Survey on Cosmetic Dermatologic Procedures reflects overall consumer views on cosmetic medical treatments ...
Breaking Medicine News(10 mins):Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3Health News:Assessment Can Help Older Drivers Keep Driving Safely, from the August 2015 Harvard Health Letter 2Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 2Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 3Health News:ASDS Survey: Half of Consumers Considering Cosmetic Procedure 4
... -- The American College of Physicians (ACP) has received a ... of a patient-centered medical home (PCMH). The grant, part ... underwrite a 10-month study which began in November. ACP ... a conceptual model of care whose goal is to put ...
... 15 years, use of opioid medications to treat patients ... patients were more likely to receive opioids than patients ... the January 2 issue of JAMA. , In ... the problem of inadequately treated pain. Also, racial and ...
... January 1 issue of the journal SLEEP finds that ... cardiovascular responses during recovery from maximal exercise. These ... heart rate during recovery, and may be an early ... study, authored by Trent A. Hargens, PhD, of Virginia ...
... treat chronic and recurrent tonsillitis substantially improve a patients ... to two new studies published as a supplement to ... , In one study involving 72 adults, patients showed ... Adenoid Health Status Instrument (TAHSI), a scale used to ...
... ... Boards Merge, CANTON, Ohio, Dec. 31 Two county boards have,merged ... Alcohol and Drug Addiction Services Board of Stark County are,now a single ... "The combined Board will create a stronger advocate for people with,mental ...
... YORK, Dec. 31 The New Year ... finally lose those excess pounds in a ... to this report from GlaxoSmithKline at:, http://media.medialink.com/WebNR.aspx?story=34274 ... audio, text, graphics and,photos for free and ...
Cached Medicine News:Health News:American College of Physicians receives grant to study cost of patient-centered medical home 2Health News:Use of opioids for pain in ERs on the rise, but racial differences in use still exist 2Health News:Use of opioids for pain in ERs on the rise, but racial differences in use still exist 3Health News:Undiagnosed OSA patients have altered cardiovascular responses during exercise recovery 2Health News:Undiagnosed OSA patients have altered cardiovascular responses during exercise recovery 3Health News:Combined Boards Provide Better Care to More Clients More Efficiently 2
... just about everything imaginable that might have to ... is designed for long term storage under archival ... over metal systems is overlooked, while the natural ... of desiccator and insulator, providing an environment that ...
A prepared Microscope Slide Cataloging and Storage System....
... Our moisture resistant, plastic covered ... high, each supporting up to 500 ... weight. Each box accommodates 2000 slides ... your varied storage requirements. Come unassembled ...
Shandon Plastic Slide Boxes...
Medicine Products: